Similar companies
Income Statement (USD)
Q2 '25 | QoQ | |
---|---|---|
Revenue | 203M | 4.9% |
Gross Profit | 140M | 14.7% |
Cost of Revenue | 64M | 11.7% |
Operating expense | 156M | 8.8% |
Net Income | -14M | 73.5% |
EBITDA | 7.7M | 164.7% |
Balance Sheet (USD)
Q2 '25 | QoQ | |
---|---|---|
Total Assets | 837M | 1.7% |
Total Liabilities | 379M | 3.8% |
Total Equity | 458M | 0% |
Shares Outstanding | 40M | 0.8% |
Cash Flow (USD)
Q2 '25 | QoQ | |
---|---|---|
Cash from operations | 12M | 163.3% |
Cash from investing | -7.1M | 5.4% |
Cash from financing | 2.6M | 505.5% |
EPS
Financial Highlights for Orthofix Medical in Q2 '25
Orthofix Medical reported a revenue of 203M, which is a 4.9% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 140M, marking a 14.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 64M, a -11.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 156M, showing a -8.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -14M, showing a 73.5% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 7.7M, showing a 164.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Orthofix Medical with growth in revenue, gross profit, and net income.